TY - JOUR
T1 - EspH utilizes phosphoinositide and Rab binding domains to interact with plasma membrane infection sites and Rab GTPases*
AU - Nandi, Ipsita
AU - Ramachandran, Rachana Pattani
AU - Shalev, Deborah E.
AU - Schneidman-Duhovny, Dina
AU - Shtuhin-Rahav, Raisa
AU - Melamed-Book, Naomi
AU - Zlotkin-Rivkin, Efrat
AU - Rouvinski, Alexander
AU - Rosenshine, Ilan
AU - Aroeti, Benjamin
N1 - Publisher Copyright:
© 2024 The Author(s). Published with license by Taylor & Francis Group, LLC.
PY - 2024
Y1 - 2024
N2 - Enteropathogenic E. coli (EPEC) is a Gram-negative bacterial pathogen that causes persistent diarrhea. Upon attachment to the apical plasma membrane of the intestinal epithelium, the pathogen translocates virulence proteins called effectors into the infected cells. These effectors hijack numerous host processes for the pathogen’s benefit. Therefore, studying the mechanisms underlying their action is crucial for a better understanding of the disease. We show that translocated EspH interacts with multiple host Rab GTPases. AlphaFold predictions and site-directed mutagenesis identified glutamic acid and lysine at positions 37 and 41 as Rab interacting residues in EspH. Mutating these sites abolished the ability of EspH to inhibit Akt and mTORC1 signaling, lysosomal exocytosis, and bacterial invasion. Knocking out the endogenous Rab8a gene expression highlighted the involvement of Rab8a in Akt/mTORC1 signaling and lysosomal exocytosis. A phosphoinositide binding domain with a critical tyrosine was identified in EspH. Mutating the tyrosine abolished the localization of EspH at infection sites and its capacity to interact with the Rabs. Our data suggest novel EspH-dependent mechanisms that elicit immune signaling and membrane trafficking during EPEC infection.
AB - Enteropathogenic E. coli (EPEC) is a Gram-negative bacterial pathogen that causes persistent diarrhea. Upon attachment to the apical plasma membrane of the intestinal epithelium, the pathogen translocates virulence proteins called effectors into the infected cells. These effectors hijack numerous host processes for the pathogen’s benefit. Therefore, studying the mechanisms underlying their action is crucial for a better understanding of the disease. We show that translocated EspH interacts with multiple host Rab GTPases. AlphaFold predictions and site-directed mutagenesis identified glutamic acid and lysine at positions 37 and 41 as Rab interacting residues in EspH. Mutating these sites abolished the ability of EspH to inhibit Akt and mTORC1 signaling, lysosomal exocytosis, and bacterial invasion. Knocking out the endogenous Rab8a gene expression highlighted the involvement of Rab8a in Akt/mTORC1 signaling and lysosomal exocytosis. A phosphoinositide binding domain with a critical tyrosine was identified in EspH. Mutating the tyrosine abolished the localization of EspH at infection sites and its capacity to interact with the Rabs. Our data suggest novel EspH-dependent mechanisms that elicit immune signaling and membrane trafficking during EPEC infection.
KW - Enteropathogenic e. coli
KW - EspH
KW - Rab GTPases
KW - Rho GTPases
KW - bacterial invasion
KW - host-pathogen interactions
KW - lysosomal exocytosis
KW - phosphoinositide binding domain (PBD) PI3K/Akt/mTORC1 signaling
KW - phosphoinositides (PIs)
KW - type III secreted effectors
UR - http://www.scopus.com/inward/record.url?scp=85205084222&partnerID=8YFLogxK
U2 - 10.1080/19490976.2024.2400575
DO - 10.1080/19490976.2024.2400575
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39312647
AN - SCOPUS:85205084222
SN - 1949-0976
VL - 16
JO - Gut Microbes
JF - Gut Microbes
IS - 1
M1 - 2400575
ER -